Related Experiment Video
Updated: Sep 23, 2026

Neuron-Macrophage Co-cultures to Activate Macrophages Secreting Molecular Factors with Neurite Outgrowth Activity
Published on: March 30, 2018
Granulocyte macrophage colony stimulating factor (GM-CSF) activity is regulated by a GM-CSF binding molecule in
Roni Mirski1, Fanny Reichert, Avihu Klar
1Department of Anatomy and Cell Biology, Hebrew University-Hadassah Medical School, P.O.B. 12272, Jerusalem 91120, Israel.
Abstract:
The hematopoietic factor and inflammatory cytokine GM-CSF is involved in PNS and CNS injury and disease, and in macrophage and microglia function regulation. We presently document that injury to PNS axons induces in vivo production of GM-CSF-inhibitor and GM-CSF-augmenter activities. GM-CSF-inhibitor activity was detected in extract and conditioned medium (CM) of injured PNS but not in extract of intact PNS, and was removed from CM by GM-CSF affinity chromatography, suggesting it is carried by a secreted GM-CSF binding molecule. CM further displayed GM-CSF-augmenter activity along with GM-CSF-inhibitor activity but at contrasting concentrations; augmentation at lowest and inhibition at highest. GM-CSF activity is thus regulated during Wallerian degeneration (WD); augmenter activity characterizes the onset and inhibitor activity the later stages of WD.
Insights
Injury to peripheral nervous system (PNS) axons triggers the production of both GM-CSF inhibitor and augmenter activities during Wallerian degeneration. These activities are regulated, with augmentation at the onset and inhibition at later stages.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a key hematopoietic factor and inflammatory cytokine.
- GM-CSF plays a crucial role in regulating macrophage and microglia function, impacting both peripheral nervous system (PNS) and central nervous system (CNS) injury and disease.
Purpose of the Study:
- To investigate the regulation of GM-CSF activity following peripheral nervous system (PNS) axon injury.
- To identify the presence and characteristics of GM-CSF-modulating activities during Wallerian degeneration (WD).
Main Methods:
- Analysis of extracts and conditioned media (CM) from injured and intact PNS tissues.
- Detection of GM-CSF inhibitor and augmenter activities in biological samples.
- Utilized GM-CSF affinity chromatography to isolate and identify the inhibitor molecule.
Main Results:
- PNS axon injury induces in vivo production of both GM-CSF-inhibitor and GM-CSF-augmenter activities.
- GM-CSF-inhibitor activity was detected in injured PNS extracts and CM, but not in intact PNS.
- A secreted GM-CSF binding molecule was identified as the carrier of the inhibitor activity.
- CM exhibited both inhibitor and augmenter activities at different concentrations, with augmentation at lower and inhibition at higher levels.
Conclusions:
- GM-CSF activity is dynamically regulated during Wallerian degeneration (WD).
- Augmenter activity is associated with the early stages of WD, while inhibitor activity characterizes later stages.
- These findings highlight a complex regulatory mechanism of GM-CSF during nerve injury and regeneration.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Differentiation of Common Myeloid Progenitor Cells
Neurogenesis and Regeneration of Nervous Tissue
